Vernal Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 61

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $41M

  • Investors
  • 6

Vernal Biosciences General Information

Description

Operator of an mRNA manufacturing company intended to provide high purity from concept to clinical trials, on a transactional basis. The company focuses on mRNA and LNP-mRNA manufacturing for use in cells, animals, and humans to address all mRNA-based life science needs, enabling research professionals with on-demand, high-purity mRNA for all of their research and development needs.

Contact Information

Website
www.vernal.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 261 Mountain View Drive
  • Colchester, VT 05446
  • United States
+1 (802)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 261 Mountain View Drive
  • Colchester, VT 05446
  • United States
+1 (802)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vernal Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Jun-2023 $41M Completed Generating Revenue
1. Seed Round 24-May-2021 Completed Generating Revenue
To view Vernal Biosciences’s complete valuation and funding history, request access »

Vernal Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Vernal Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vernal Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an mRNA manufacturing company intended to provide high purity from concept to clinical trials, on a transact
Biotechnology
Colchester, VT
61 As of 2023

Somerville, MA
 

Oklahoma City, OK
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vernal Biosciences Competitors (61)

One of Vernal Biosciences’s 61 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Cytovance Biologics Formerly PE-Backed Oklahoma City, OK
etherna Formerly VC-backed Niel, Belgium
Verge Labs Venture Capital-Backed San Francisco, CA
Arvinas Formerly VC-backed New Haven, CT
You’re viewing 5 of 61 competitors. Get the full list »

Vernal Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vernal Biosciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ampersand Capital Partners Growth/Expansion Minority
Charles River Laboratories International Corporation Minority
Dynamk Capital Venture Capital Minority
Echo Investment Capital PE/Buyout Minority
Alloy Therapeutics VC-Backed Company Minority
You’re viewing 5 of 6 investors. Get the full list »

Vernal Biosciences FAQs

  • When was Vernal Biosciences founded?

    Vernal Biosciences was founded in 2020.

  • Where is Vernal Biosciences headquartered?

    Vernal Biosciences is headquartered in Colchester, VT.

  • What is the size of Vernal Biosciences?

    Vernal Biosciences has 61 total employees.

  • What industry is Vernal Biosciences in?

    Vernal Biosciences’s primary industry is Biotechnology.

  • Is Vernal Biosciences a private or public company?

    Vernal Biosciences is a Private company.

  • What is the current valuation of Vernal Biosciences?

    The current valuation of Vernal Biosciences is .

  • What is Vernal Biosciences’s current revenue?

    The current revenue for Vernal Biosciences is .

  • How much funding has Vernal Biosciences raised over time?

    Vernal Biosciences has raised $42.5M.

  • Who are Vernal Biosciences’s investors?

    Ampersand Capital Partners, Charles River Laboratories International, Dynamk Capital, Echo Investment Capital, and Alloy Therapeutics are 5 of 6 investors who have invested in Vernal Biosciences.

  • Who are Vernal Biosciences’s competitors?

    Genetix Biotherapeutics, Cytovance Biologics, etherna, Verge Labs, and Arvinas are some of the 61 competitors of Vernal Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process